ARM Stock Wins a New Street-High Price Target

Designing chips in-house has become quite a thing and Arm Holdings (NASDAQ:ARM) is now claiming a piece of this action too. Shares climbed by 19% in Wednesday’s session after the company announced the official launch of its Arm AGI processor.

Claim 30% Off TipRanks Premium

  • Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions

  • Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

For over three decades, the UK firm has generated revenue by licensing its processor instruction sets and core designs to the world’s leading chip manufacturers, collecting a fee on every chip made with its technology. Now, it is entering the business of creating its own physical processors for the first time. This marks a big change in its approach, moving from supporting companies such as Nvidia, Apple, and Google, to directly competing with them in the hardware space.

The Arm AGI processor is built specifically for AI data centers and agentic AI workloads. This not only moves the company beyond its standard IP licensing and Compute Subsystem model by offering clients a silicon solution for Arm-based infrastructure, but according to the firm, it also broadens its TAM (total addressable market) to over $1 trillion by 2030.

During his keynote at the “Arm Everywhere” event, CEO Rene Haas highlighted the recent surge in AI “agents,” noting that the resulting query traffic is straining data center CPU capacity, creating a processing bottleneck and driving the need for roughly four times more CPU cores per gigawatt for these workloads. Arm asserts that the new AGI processor delivers more than double the performance per watt compared with x86 processors. The company said Meta Platforms is the lead partner and co-developer, alongside other major collaborators in the hyperscaler, semiconductor, and software sectors.

The company also confirmed its previously issued F4Q guide, and set long-term financial targets for FY31, based on projected revenue of $25 billion, with $15 billion anticipated to come from sales of the newly introduced AGI processor.

The company conveyed confidence that competing with some of its existing clients is unlikely. Although Guggenheim’s John DiFucci, an analyst specializing in software and who ranks among the top 3% on Wall Street, thinks there is “logic in their viewpoint,” he believes it is “worth monitoring the potential for future conflicts to arise.”

Nevertheless, among the companies he covers, DiFucci has claimed that Arm is one of three names (the others being Oracle and Microsoft) that will probably see “clear benefits from the advancement of AI technologies.”

“While we are confident in the company’s ability to execute, there is always risk in launching into new opportunities, especially something this transformational,” the 5-star analyst went on to say. “Therefore, we are taking a prudent approach to the newly issued long-term guidance, and will continue to monitor execution going forward.”

That hasn’t stopped DiFucci from raising his price target from $201 to a new Street-high of $240, suggesting the shares will gain another 51% in the months ahead. DiFucci’s rating stays a Buy. (To watch DiFucci’s track record, click here)

20 other analysts join DiFucci in the bull camp, while an additional 3 Holds and 1 Sell can’t detract from a Strong Buy consensus rating. That said, the broader Street is taking a more measured stance, with an average price target of $174 implying a more modest ~10% upside from current levels. (See ARM stock forecast)

Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Disclaimer & DisclosureReport an Issue

AGI-6,23%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin